Nationwide study of the treatment options of lentigo maligna and recurrence rates in the Netherlands by J. Zoutendijk, L. Hollestein, T. Nijsten, A. Mooyaart, R. van den Bos

Get full text

The Dutch Early-Stage Melanoma Study (D-ESMEL): a Discovery Set and Validation Cohort to Predict the Absolute Risk of Distant Metastases in Stage I/II Cutaneous Melanoma by C. Zhou, A. Mooyaart, T. Kerkour, M. Louwman, M. Wakkee, R. Voorham, A. Gijsbers-Bruggink, T. Nijsten, L. Hollestein

Get full text

The Dutch Keratinocyte Cancer Collaborative: real-world linked health care data to identify and follow-up patients with advanced cutaneous squamous carcinoma on a nationwide level by C. Eggermont, L. Hollestein, M. Louwman, K. Schreuder, A. Bruggink, Q. Voorham, A. Mooyaart, T. Nijsten, M. Wakkee

Get full text

Integrating a Clinicopathological Risk Prediction Model into the European Guideline for Cutaneous Squamous Cell Carcinoma by O. Steijlen, L. Pozza, B. Rentroia-Pacheco, C. Eggermont, D. Bellomo, S. Alex, J. Dwarkasing, A. Mooyaart, L. Hollestein, M. Wakkee

Get full text